Whitehawk Therapeutics (WHWK) Net Margin: 2018-2025
Historic Net Margin for Whitehawk Therapeutics (WHWK) over the last 4 years, with Mar 2025 value amounting to -201.92%.
- Whitehawk Therapeutics' Net Margin rose 13972.00% to -201.92% in Q1 2025 from the same period last year, while for Mar 2025 it was -215.40%, marking a year-over-year increase of 6179.00%. This contributed to the annual value of -245.13% for FY2024, which is 2491.00% up from last year.
- Per Whitehawk Therapeutics' latest filing, its Net Margin stood at -201.92% for Q1 2025, which was up 20.01% from -252.42% recorded in Q4 2024.
- Over the past 5 years, Whitehawk Therapeutics' Net Margin peaked at 55,470.06% during Q3 2021, and registered a low of -4,563.33% during Q1 2021.
- For the 3-year period, Whitehawk Therapeutics' Net Margin averaged around -249.06%, with its median value being -252.42% (2024).
- In the last 5 years, Whitehawk Therapeutics' Net Margin skyrocketed by 5,672,201bps in 2021 and then slumped by 5,581,103bps in 2022.
- Over the past 5 years, Whitehawk Therapeutics' Net Margin (Quarterly) stood at -114.21% in 2021, then plummeted by 15,196bps to -266.18% in 2022, then spiked by 900bps to -257.18% in 2023, then spiked by 475bps to -252.42% in 2024, then spiked by 13,972bps to -201.92% in 2025.
- Its last three reported values are -201.92% in Q1 2025, -252.42% for Q4 2024, and -173.95% during Q3 2024.